1. Home
  2. PRLD vs YTRA Comparison

PRLD vs YTRA Comparison

Compare PRLD & YTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • YTRA
  • Stock Information
  • Founded
  • PRLD 2016
  • YTRA 2005
  • Country
  • PRLD United States
  • YTRA India
  • Employees
  • PRLD N/A
  • YTRA N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • YTRA Transportation Services
  • Sector
  • PRLD Health Care
  • YTRA Consumer Discretionary
  • Exchange
  • PRLD Nasdaq
  • YTRA Nasdaq
  • Market Cap
  • PRLD 73.7M
  • YTRA 71.0M
  • IPO Year
  • PRLD 2020
  • YTRA N/A
  • Fundamental
  • Price
  • PRLD $1.05
  • YTRA $1.22
  • Analyst Decision
  • PRLD Strong Buy
  • YTRA Strong Buy
  • Analyst Count
  • PRLD 2
  • YTRA 1
  • Target Price
  • PRLD $4.50
  • YTRA $4.00
  • AVG Volume (30 Days)
  • PRLD 611.2K
  • YTRA 109.1K
  • Earning Date
  • PRLD 02-13-2025
  • YTRA 02-12-2025
  • Dividend Yield
  • PRLD N/A
  • YTRA N/A
  • EPS Growth
  • PRLD N/A
  • YTRA N/A
  • EPS
  • PRLD N/A
  • YTRA N/A
  • Revenue
  • PRLD $3,000,000.00
  • YTRA $66,249,516.00
  • Revenue This Year
  • PRLD N/A
  • YTRA N/A
  • Revenue Next Year
  • PRLD N/A
  • YTRA N/A
  • P/E Ratio
  • PRLD N/A
  • YTRA N/A
  • Revenue Growth
  • PRLD N/A
  • YTRA 33.74
  • 52 Week Low
  • PRLD $0.80
  • YTRA $1.07
  • 52 Week High
  • PRLD $6.80
  • YTRA $1.93
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 45.27
  • YTRA 39.31
  • Support Level
  • PRLD $0.98
  • YTRA $1.15
  • Resistance Level
  • PRLD $1.43
  • YTRA $1.24
  • Average True Range (ATR)
  • PRLD 0.12
  • YTRA 0.06
  • MACD
  • PRLD -0.02
  • YTRA 0.00
  • Stochastic Oscillator
  • PRLD 14.14
  • YTRA 56.52

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About YTRA Yatra Online Inc.

Yatra Online Inc is an Indian consumer travel platform provider and online travel agent. The company is organized into the following business segments; Air Ticketing which derives maximum revenue, Hotels and Packages, and Other Services. It mainly provides travel-related services, which include domestic and international air ticketing, hotel bookings, homestays, holiday packages, bus ticketing, rail ticketing, activities and ancillary services. It also involves hosting advertisements on its internet websites, the sale of rail and bus tickets, and facilitating website access to travel insurance companies. Some of its applications include Yatra Mini, Yatra Web Check-In, Yatra Corporate, and Travelguru HomeStay.

Share on Social Networks: